Brainstorm Cell Therapeutics Inc.
BCLI | OTC
$0.82
$0.00 (-0.01%)
Nov 2, 2026, 1:16 PM ET · Market open
Market Data
Market Cap $9.05M
Enterprise Value N/A
Beta 0.69
Average Volume N/A
Shares Outstanding (Diluted) 11.01M
Shares Change YoY N/A
Institutional Ownership N/A
Exchange OTC
ISIN N/A
Price Performance
Price Change 1M 78.3%
Price Change 3M 36.7%
Price Change 6M 17.2%
Price Change YTD 34.4%
Price Change 1Y -47.1%
Price Change 3Y -96.5%
Price Change 5Y -98.7%
1M CAGR (ann.) N/A
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR N/A
Financial Health
Net Debt $96K
Total Debt N/A
Cash & Short-Term Investments N/A
Total Assets N/A
Current Ratio N/A
Quick Ratio N/A
Debt / Equity Ratio N/A
Debt / EBITDA N/A
Debt / FCF N/A
OCF / Debt N/A
Interest Coverage N/A
Altman Z-Score N/A
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin N/A
Operating Profit Margin -1283.6%
EBITDA Margin N/A
Net Profit Margin N/A
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue N/A
SBC Impact (per share) -21.8%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y 66.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 40.6%
EPS CAGR 5Y 23.2%
EPS CAGR 10Y 12.6%
FCF CAGR 3Y 21.9%
FCF CAGR 5Y 4.5%
FCF CAGR 10Y -9.6%
Income Statement
Revenue $849K
Gross Profit N/A
Operating Income N/A
EBITDA N/A
Net Income $-10.85M
EPS (Diluted) -$1.50
Revenue / Employee $31.44K
Profit / Employee $-401.7K
Employees N/A
Add to Watchlist
Select watchlists to add or remove BCLI